Literature DB >> 9531990

Mono and double modified teicoplanin aglycon derivatives on the amino acid no. 7; structure-activity relationship.

A Y Pavlov1, M N Preobrazhenskaya, A Malabarba, R Ciabatti, L Colombo.   

Abstract

A series of 7d-aminomethylated derivatives (mono modified) and their amides (double modified) at the amino acid No. 7 of teicoplanin aglycon were prepared with the aim of obtaining activity against vancomycin-resistant VanA enterococci. Among mono modified compounds, the 7d-n-decylaminomethyl derivative was the most active against VanA enterococci (4 micrograms/ml). Amides of the latter with 3-dimethylamino-propylamine or methylamine were found to be up to four times more active against glycopeptide-susceptible Gram-positive bacteria, and up to four times less active against VanA enterococci than the starting compound.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531990     DOI: 10.7164/antibiotics.51.73

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.

Authors:  Sung Joon Kim; Lynette Cegelski; Maria Preobrazhenskaya; Jacob Schaefer
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

2.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

Review 3.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

4.  Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity.

Authors:  Elena I Moiseenko; Réka Erdei; Natalia E Grammatikova; Elena P Mirchink; Elena B Isakova; Eleonora R Pereverzeva; Gyula Batta; Andrey E Shchekotikhin
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.